Cargando…

Withdrawing Antipsychotics for Challenging Behaviours in Adults with Intellectual Disabilities: Experiences and Views of Experts by Experience

People with intellectual disabilities (PwID) are frequently prescribed long-term antipsychotics for behaviours that challenge (BtC) despite the lack of proven effectiveness and the increased risks for side effects of these medications in this population. National and international good clinical prac...

Descripción completa

Detalles Bibliográficos
Autores principales:	de Kuijper, Gerda, de Haan, Joke, Deb, Shoumitro, Shankar, Rohit
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9736624/ https://www.ncbi.nlm.nih.gov/pubmed/36497711 http://dx.doi.org/10.3390/ijerph192315637

Ejemplares similares

Withdrawing Antipsychotics for Challenging Behaviours in Adults with Intellectual Disabilities: Experiences and Views of Prescribers
por: de Kuijper, Gerda, et al.
Publicado: (2022)

UK psychiatrists’ experience of withdrawal of antipsychotics prescribed for challenging behaviours in adults with intellectual disabilities and/or autism
por: Deb, Shoumitro, et al.
Publicado: (2020)

Association between epilepsy and challenging behaviour in adults with intellectual disabilities: systematic review and meta-analysis
por: Deb, Shoumitro, et al.
Publicado: (2020)

Causes of and Alternatives to Medication for Behaviours That Challenge in People with Intellectual Disabilities: Direct Care Providers’ Perspectives
por: Deb, Shoumitro (Shoumi), et al.
Publicado: (2022)

Support staff liaising effectively with professionals for the rational use of psychotropics for behaviours that challenge in adults with intellectual disabilities: Findings from a co-design event
por: Limbu, Bharati, et al.
Publicado: (2022)

Intellectual disability and antipsychotics
por: Iñiguez, I. Cuevas, et al.
Publicado: (2021)

Exploring the association of staff characteristics with staff perceptions of quality of life of individuals with intellectual disabilities and challenging behaviours
por: Bruinsma, Eke, et al.
Publicado: (2022)

Antipsychotics withdrawal in adults with intellectual disability and challenging behaviour: study protocol for a multicentre double-blind placebo-controlled randomised trial
por: Beumer, Sylvie, et al.
Publicado: (2021)

Challenging behaviours: Views and preferences of people with intellectual disabilities
por: Wolkorte, Ria, et al.
Publicado: (2019)

Difficulties in Addressing Diagnostic, Treatment and Support Needs in Individuals with Intellectual Disability and Persistent Challenging Behaviours: A Descriptive File Study of Referrals to an Expertise Centre
por: de Kuijper, Gerda, et al.
Publicado: (2023)

Short-term PsychoEducation for Carers To Reduce Over Medication of people with intellectual disabilities (SPECTROM): study protocol
por: Deb, Shoumitro, et al.
Publicado: (2020)

Association between epilepsy and psychiatric disorders in adults with intellectual disabilities: systematic review and meta-analysis
por: Akrout Brizard, Basma, et al.
Publicado: (2021)

Short-Term Psycho-Education for Caregivers to Reduce Overmedication of People with Intellectual Disabilities (SPECTROM): Development and Field Testing
por: Deb, Shoumitro (Shoumi), et al.
Publicado: (2021)

Support staff’s perceptions of discontinuing antipsychotics in people with intellectual disabilities in residential care: A mixed‐method study
por: Kleijwegt, Bas, et al.
Publicado: (2019)

Non‐pharmacological interventions for challenging behaviours of adults with intellectual disabilities: A meta‐analysis
por: Bruinsma, E., et al.
Publicado: (2020)

Influence of the organizational environment on challenging behaviour in people with intellectual disabilities: Professionals’ views
por: Olivier‐Pijpers, Vanessa C., et al.
Publicado: (2018)

Aligning quality of life and guidelines for off-label psychotropic drugs in adults with intellectual disabilities and challenging behaviour
por: Laermans, P., et al.
Publicado: (2023)

The experiences of 585 people when they tried to withdraw from antipsychotic drugs
por: Read, John
Publicado: (2022)

People with intellectual disabilities and harmful sexual behaviour: Professionals' views on the barriers to prevent harm
por: Svae, Gøril Brevik, et al.
Publicado: (2022)

Improving knowledge of psychotropic prescribing in people with Intellectual Disability in primary care
por: Shankar, Rohit, et al.
Publicado: (2018)

Retrospective Analysis of a Single Centre Experience of the Pharmacological Management of Patients With Intellectual Disability & Challenging Behaviour Across Three Audit Cycles
por: Khodabux, Nusra, et al.
Publicado: (2023)

Evaluation of Serum Prolactin Levels in Intellectually Disabled Patients Using Antipsychotic Medications
por: Lambert, Tammy L, et al.
Publicado: (2012)

Metformin for the treatment of antipsychotic-induced metabolic disturbances in people with intellectual and developmental disabilities
por: Stogios, Nicolette, et al.
Publicado: (2023)

Cardiometabolic Effects of Antipsychotics in Challenging Behavior and Neuropsychiatric Symptoms in Patients With Intellectual Disability
por: Takano, Tomoyuki
Publicado: (2023)

Intellectual Disability and Dental Services: Experience from Israel
por: Feldberg, Ilan, et al.
Publicado: (2014)

Living with support: Experiences of people with mild intellectual disability
por: Giesbers, Sanne A. H., et al.
Publicado: (2018)

Personal and sexual boundaries: the experiences of people with intellectual disabilities
por: Svae, Gøril Brevik, et al.
Publicado: (2022)

Families’ Experiences on Safety Needs of Children with Intellectual Disability
por: Modula, Mantji Juliah, et al.
Publicado: (2022)

Pharmacogenomics: an opportunity for personalised psychotropic prescribing in adults with intellectual disabilities
por: Perera, Bhathika, et al.
Publicado: (2022)

Experiences with general practitioners described by families of children with intellectual disabilities and challenging behaviour: a qualitative study
por: Fredheim, Terje, et al.
Publicado: (2011)

Mental health professionals’ views and experiences of antipsychotic reduction and discontinuation
por: Cooper, Ruth E., et al.
Publicado: (2019)

Morbidity and mortality of women and men with intellectual and developmental disabilities newly initiating antipsychotic drugs
por: Vigod, Simone N., et al.
Publicado: (2016)

Antipsychotic Use With and Without Comorbid Psychiatric Diagnosis Among Adults with Intellectual and Developmental Disabilities
por: Lunsky, Yona, et al.
Publicado: (2017)

A systematic review of hospital experiences of people with intellectual disability
por: Iacono, Teresa, et al.
Publicado: (2014)

Health Policy for Persons with Intellectual Disability: Experiences from Israel
por: Halperin, Ilana, et al.
Publicado: (2005)

Caries Experience of Adults with Intellectual Disability in the Western Part of Germany
por: Schmidt, Peter, et al.
Publicado: (2021)

Experiences of people with intellectual disability and dementia: A systematic review
por: Jacobs, Paula, et al.
Publicado: (2022)

Persons with Intellectual Disability: Sexual Behaviour, Knowledge and Assertiveness
por: Brkić-Jovanović, Nina, et al.
Publicado: (2021)

Under representation of people with epilepsy and intellectual disability in research
por: Shankar, Rohit, et al.
Publicado: (2018)

Paediatricians’ Views on Pain in Children with Profound Intellectual and Multiple Disabilities
por: Petigas, Lucie, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_v1e3dp7rfes428tt3lkaadn7fs